Asthma<unk>  is given by metered-dose inhaler or nebulizer for maintenance and prophylactic treatment of asthma, including patients who require oral corticosteroids and those who may benefit from a systemic dose reduction. Inflammatory bowel disease Formulations of delayed-release<unk>  are an effective treatment for mild-to-moderately active Crohn's disease involving the ileum and/or ascending colon. A Cochrane review found evidence for up to three months (but not longer) of maintenance of remission in Crohn's disease.<unk>  assists in the induction of remission in people with active ulcerative colitis.<unk>  is highly effective and recommended as the drug of choice in microscopic colitis, for induction and maintenance of remission, and for both the lymphocytic colitis and collagenous colitis forms. Allergic rhinitis<unk>  in the form of nasal sprays is a treatment for allergic rhinitis. Eosinophilic esophagitis Topical<unk>  has considerable effects in eosinophilic esophagitis. For this use, it is formulated as a tablet that disperses in the mouth, and sold under the trade name Jorveza. Berger's disease<unk>  (Tarpeyo) is indicated to reduce proteinuria (increased protein levels in the urine) in adults with primary immunoglobulin A (IgA) nephropathy (Berger's disease) at risk of rapid disease progression.
Budesonide
Fluticasone furoate
Flumetasone
Fluticasone
Fluticasone propionate
Clobetasone
Diflorasone diacetate
Theophylline